The Multiple Role of Bromide Ion in PPCPs Degradation under UV/Chlorine Treatment.

This study investigated the role of bromide ions in the degradation of nine pharmaceuticals and personal care products (PPCPs) during the UV/chlorine treatment of simulated drinking water containing 2.5 mgC L-1 natural organic matter (NOM). The kinetics of contributions from UV irradiation and from oxidation by free chlorine, free bromine, hydroxyl radical and reactive halogen species were evaluated. The observed loss rate constants of PPCPs in the presence of 10 μM bromide were 1.6-23 times of those observed in the absence of bromide (except for iopromide and ibuprofen). Bromide was shown to play multiple roles in PPCP degradation. It reacts rapidly with free chlorine to produce a trace amount of free bromine, which then contributes to up to 55% of the degradation of some PPCPs during 15 min of UV/chlorine treatment. Bromide was also shown to reduce the level of HO• and to change the reactive chlorine species to bromine-containing species, which resulted in decreases in ibuprofen degradation and enhancement in carbamazepine and caffeine degradation, respectively. Reactive halogen species contributed to between 37 and 96% of the degradation of the studied PPCPs except ibuprofen in the presence of 10 μM bromide ion. The effect of bromide is non-negligible during the UV/chlorine treatment.